Association between dynamic trajectories of serum tumor markers and survival outcomes in patients with extensive-stage small cell lung cancer: a retrospective cohort study
Key Points
This research aims to evaluate how changes in serum tumor markers relate to survival outcomes in extensive-stage small cell lung cancer.
Performed a retrospective cohort study
Monitored serum levels of NSE, CEA, and CYFRA21-1 over time
Analyzed the correlation between marker dynamics and survival outcomes
Dynamic monitoring of tumor markers correlates with improved prognostic predictions
Higher levels of NSE, CEA, and CYFRA21-1 are associated with poorer survival outcomes
Patients with regular monitoring show better management and potential survival benefits
Abstract
Dynamic monitoring of NSE, CEA, and CYFRA21-1 provides a valuable approach for prognostic prediction in patients with ES-SCLC.
Association between dynamic trajectories of serum tumor markers and survival outcomes in patients with extensive-stage small cell lung cancer: a retrospective cohort study | Synapse